OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An overview of ghrelinO-acyltransferase inhibitors: a literature and patent review for 2010-2019
Jacob E. Moose, Katelyn A. Leets, Nilamber A. Mate, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 8, pp. 581-593
Open Access | Times Cited: 22

Showing 22 citing articles:

AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity
Muhammad Sufyan Vohra, Khaled Benchoula, Christopher J. Serpell, et al.
European Journal of Pharmacology (2021) Vol. 915, pp. 174611-174611
Closed Access | Times Cited: 103

Rocking the MBOAT: Structural insights into the membrane bound O-acyltransferase family
Claire E. Coupland, T. Bertie Ansell, Mark S.P. Sansom, et al.
Current Opinion in Structural Biology (2023) Vol. 80, pp. 102589-102589
Open Access | Times Cited: 13

The antidiabetic effect of safflower yellow by regulating the GOAT/ghrelin/GHS-R1a/cAMP/TRPM2 pathway
Yunxiao Ma, Haifeng Zhang, Qihui Yan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders
Eva Fritz, Nicolas Singewald, Dimitri De Bundel
Frontiers in Synaptic Neuroscience (2020) Vol. 12
Open Access | Times Cited: 34

Gut peptides and the microbiome: focus on ghrelin
Natasha Leeuwendaal, John F. Cryan, Harriët Schellekens
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 2, pp. 243-252
Open Access | Times Cited: 32

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor
Gianfabio Giorgioni, Fabio Del Bello, Wilma Quaglia, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3098-3118
Open Access | Times Cited: 15

Small molecule inhibitors of intestinal epithelial anion exchanger SLC26A3 (DRA) with a luminal, extracellular site of action
Onur Çil, Marc O. Anderson, Lívia de Souza Gonçalves, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115149-115149
Open Access | Times Cited: 8

Ghrelin octanoylation by ghrelinO-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling
Tasha R. Davis, Mariah R. Pierce, Sadie X. Novak, et al.
Open Biology (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 19

Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects
Igor Rubinić, Marija Kurtov, Robert Likić
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2

Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies
Susanna Bianzano, Andrea Henrich, Lena Herich, et al.
Metabolism (2023) Vol. 143, pp. 155550-155550
Closed Access | Times Cited: 6

Ghrelin as a possible biomarker and maintaining factor in patients with eating disorders reporting childhood traumatic experiences
Eleonora Rossi, Emanuele Cassioli, Veronica Gironi, et al.
European Eating Disorders Review (2021) Vol. 29, Iss. 4, pp. 588-599
Open Access | Times Cited: 13

Small‐Molecule Modulation of Protein Lipidation: From Chemical Probes to Therapeutics
Zhen Wang, Jiafu Ying, Xuanpu Zhang, et al.
ChemBioChem (2023) Vol. 24, Iss. 14
Closed Access | Times Cited: 4

Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
Michał Nicze, Adrianna Dec, Maciej Borówka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8202-8202
Open Access | Times Cited: 1

Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story
Andreea-Ioana Inceu, Maria Adriana Neag, Anca-Elena Crăciun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3385-3385
Open Access | Times Cited: 3

Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-β Knockin Mice During Aging
Jing Tian, Eric Y. Du, Kun Jia, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1579-1592
Open Access | Times Cited: 2

Discovery of novel inhibitors of ghrelin O-acyltransferase enzyme
Faezeh Sadat Hosseini, Alireza Ghassempour, Massoud Amanlou
Research in Pharmaceutical Sciences (2022) Vol. 17, Iss. 5, pp. 540-557
Open Access | Times Cited: 3

Ghrelin in Depression: A Promising Therapeutic Target
Mikhil Santosh Kore, Rumaiza Mamsa, Dipti Patil, et al.
Molecular Neurobiology (2024)
Closed Access

Discovery of new oxadiazolo pyridine derivatives as potent ghrelin O-acyltransferase inhibitors using molecular modeling techniques
Kaushik Sarkar, Bipasha Das, Rajesh Kumar Das
In Silico Pharmacology (2023) Vol. 11, Iss. 1
Closed Access | Times Cited: 1

Efficiency of a Lyophilizate for Dry Powder Inhalation System for Drug Delivery of Ghrelin in Monkeys
Tomomi Akita, Kahori Miyamoto, Chikamasa Yamashita
Drug Delivery Letters (2023) Vol. 14, Iss. 1, pp. 89-95
Closed Access

The role of ghrelin in normal and pathological conditions
В. А. Щербак, Natalia Arkadyevna Ishchenko, Н. М. Щербак, et al.
Medical news of the North Caucasus (2023) Vol. 18, Iss. 4
Open Access

Ghrelin in Newborns: Relation to Anthropometric Parameters, Leptin, Insulin-Like Growth Factor 1 and Insulin
В. А. Прилуцкая, А. В. Сукало, T. A. Piskun, et al.
Педиатрия Восточная Европа (2021), Iss. 4, pp. 543-558
Open Access

Page 1

Scroll to top